Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Stomach Neoplasms × Doxorubicin × Clear all

Sponsor

Conditions

Breast Neoplasms 89 Lymphoma 58 Lymphoma, Large B-Cell, Diffuse 43 Precursor Cell Lymphoblastic Leukemia-Lymphoma 33 Sarcoma 31 Lymphoma, Non-Hodgkin 27 Hodgkin Disease 23 Leukemia 20 Burkitt Lymphoma 20 Lymphoma, Mantle-Cell 18 Neoplasms 16 Triple Negative Breast Neoplasms 14 Lymphoma, Follicular 14 Lymphoma, B-Cell 12 Carcinoma, Hepatocellular 12 Lymphoma, Large-Cell, Anaplastic 11 Neuroblastoma 10 Multiple Myeloma 10 Breast Neoplasms, Male 10 Neoplasm Metastasis 9 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8 Ovarian Neoplasms 8 Lymphoma, T-Cell, Peripheral 7 Lymphoma, T-Cell 7 Inflammatory Breast Neoplasms 7 Urinary Bladder Neoplasms 6 Osteosarcoma 6 Liposarcoma 6 Leiomyosarcoma 6 Fallopian Tube Neoplasms 6

Interventions

Oxaliplatin 47 Cisplatin 43 Fluorouracil 42 Capecitabine 41 pembrolizumab 31 Leucovorin 28 Docetaxel 22 Irinotecan 19 Paclitaxel 18 Trastuzumab 17 Bevacizumab 12 Ramucirumab 11 Cetuximab 9 Radiotherapy 8 Surgical Procedures, Operative 7 Nivolumab 7 S 1 (combination) 6 Epirubicin 6 Carboplatin 6 Sunitinib 4 Platinum 4 Mitomycin 4 trastuzumab deruxtecan 3 olaparib 3 epacadostat 3 bemarituzumab 3 Pemetrexed 3 Ipilimumab 3 Folfox protocol 3 Everolimus 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡